Shares of Constellation Brands Inc. (NYSE: STZ) were down 1% on Tuesday. The stock has gained 6% over the past one month. The company delivered strong demand for its most recent quarter helped by strong demand for its brands and changes to its portfolio. Here’s a look at three factors that work in favor of this brewer:
Revenue and profitability
Constellation reported revenue and earnings growth for the second quarter of 2023. Net sales increased 12% year-over-year to $2.7 billion, helped by strong consumer demand for its products. Adjusted EPS increased 33% to $3.17. Reported operating income increased 10% to $813 million. For fiscal year 2023, the company expects reported EPS to be $0.75-1.15 and adjusted EPS to be $11.20-11.60.
Strong performance in beer
Constellation witnessed strong performance in its beer business, driven by solid demand for its brands. In Q2, the beer business posted depletion growth of 9%, driven by strength in Modelo Especial and Corona Extra. Modelo Especial garnered the maximum share in the entire US beer category with depletion growth of over 10%. Corona Extra delivered depletion growth of 6%. The Modelo Chelada brands delivered depletion growth of over 60% in Q2.
The strong demand for its brands helped drive a 15% growth in net sales for the beer business in Q2. Operating income for the division gained 25% in the quarter. This momentum led Constellation to increase its guidance for the beer business. The company now expects net sales to grow 8-10% and operating income to grow 3-5% in FY2023.
Wine and spirits portfolio transformation
In Q2, net sales for the wine and spirits business inched up just 1% to $515.8 million, driven by an increase in bulk sales and favorable pricing. However, depletion growth was solid for its premium wine brands like Kim Crawford, Robert Mondavi and Meiomi.
The company’s efforts in revamping its wine and spirits portfolio is paying off. It has been moving from the mainstream segment and focusing more on the higher end of the market. In Q2, its largest premium and fine wine brands and craft spirits brands delivered strong depletion growth rates. As part of its strategy to premiumize its business, it divested a portion of its mainstream wine portfolio along with a couple of select premium brands to The Wine Group.
Wine and spirits DTC net sales grew 15% in Q2 while international sales grew 10%. Constellation plans to focus on the growth of its omnichannel and international footprint as it expects these channels to make up a larger portion of its mix over time and provide an important opportunity for higher-end growth.
For FY2023, wine and spirits net sales are expected to be flat to down 2% while operating income is expected to increase 3-5%. This would imply operating margin of about 24% for the year for the segment.
Click here to read the full transcript of Constellation Brands’ Q2 2023 earnings conference call
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on